Customizing solutions: Ventricular tachycardia and implantable cardioverter-defibrillator programming

Customizing solutions: Ventricular tachycardia and implantable cardioverter-defibrillator programming

Saved in:

Bibliographic Details
Main Authors:	Tatiana Pavlenko, Pedro Silva Cunha, Mário Martins Oliveira
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Revista Portuguesa de Cardiologia
Online Access:	http://www.sciencedirect.com/science/article/pii/S0870255124001902
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mitochondrial DNA Polymorphisms of Peripheral Blood Mononuclear Cells Associated with Sustained Ventricular Tachycardia in Patients with Cardioverter-Defibrillator Implantation Indications
by: Tariel Atabekov, et al.
Published: (2025-03-01)

Strategies to Reduce Recurrent Shocks Due to Ventricular Arrhythmias in Patients with an Implanted Cardioverter-Defibrillator
by: Steven H Back, et al.
Published: (2019-01-01)

Battery Longevity in Modern Implantable Cardioverter‐Defibrillators and Cardiac Resynchronization Therapy‐Defibrillators
by: Kotaro Nishino, et al.
Published: (2025-08-01)

How to Indicate Implantable Cardioverter‐Defibrillator in Patients With Malignancy
by: Naoya Kataoka, et al.
Published: (2025-08-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

How to indicate implantable cardioverter‐defibrillator in the aging population
by: Risako Orita, et al.
Published: (2025-04-01)

Incidence of Rapid Rate Non‐Sustained and Sustained Ventricular Tachycardia in Implantable Cardioverter‐Defibrillator Recipients and Its Correlation With Heart Failure Guideline‐Directed Medical Therapy Compliance
by: Muhammad Taha Khan, et al.
Published: (2025-08-01)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)

Implantable Cardioverter‐Defibrillator Programming: It Is Time to Get Things Right With a Checklist Manifesto
by: Salvatore Savona, et al.
Published: (2024-08-01)

Appropriate implantable cardioverter-defibrillator therapy triggered by heat stroke
by: Carlos Fernando Paz Mamani, et al.
Published: (2025-01-01)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
by: Hirota Kida, et al.
Published: (2025-06-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

URGENT CATHETER ABLATION OF THE ELECTRICAL STORM IN PATIENTS WITH IMPLANTED CARDIOVERTER-DEFIBRILLATOR
by: R. B. Tatarsky, et al.
Published: (2015-11-01)

Relapsed Brucellosis Manifested as Endocarditis with Vegetation on the Implantable Cardioverter Defibrillator Lead
by: Bisher Sawaf, et al.
Published: (2021-01-01)

Depression and Implantable Cardioverter‐Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death
by: Brian C. Boursiquot, et al.
Published: (2024-07-01)

Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)

Predictors of Shock‐Reduction Programming and Its Impact on Implantable Cardioverter‐Defibrillator Therapies and Mortality: The CERTITUDE Registry
by: Sebastian E. Beyer, et al.
Published: (2024-08-01)

A new approach in cardioverter-defibrillator implantation in patients with coronary artery disease
by: Т. A. Atabekov, et al.
Published: (2019-04-01)

Perioperative Management of Pacemakers (PM) and Implantable Cardioverter Defibrillators (ICD) in South Africa
by: A. Keene
Published: (2019-04-01)

Life-Threatening Coronary Vasospasm Treated by Implantable Cardioverter Defibrillator: The Warning Signs
by: Deborah Adepoju, et al.
Published: (2022-01-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy
by: Mohammad Taghi Hedayati Goudarzi, et al.
Published: (2023-01-01)

First Reported Case of Candida dubliniensis Endocarditis Related to Implantable Cardioverter-Defibrillator
by: Nooraldin Merza, et al.
Published: (2020-01-01)

Modified procedures of subcutaneous implantable cardioverter defibrillator implantation for a child with small body size
by: Satoshi Oka, et al.
Published: (2024-02-01)

Social Determinants of Health‐Related Outcomes in an Intervention Following Initial Implantable Cardioverter‐Defibrillator Implantation
by: Megan M. Streur, et al.
Published: (2025-05-01)

Serratia marcescens: A Rare Cause of Recurrent Implantable Cardioverter Defibrillator Site Infection
by: S. Hawkey, et al.
Published: (2015-01-01)

Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation
by: T. O. Bessonova, et al.
Published: (2022-04-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Transvenous versus subcutaneous implantable cardioverter defibrillator for hypertrophic cardiomyopathy: A meta-analysis
by: Xi Yang, et al.
Published: (2025-08-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-04-01)

Implantable cardioverter defibrillator - powerful weapon in primary and secondary prevention of sudden cardiac death
by: Kostić Tomislav, et al.
Published: (2019-01-01)

Biotronik Implantable Cardioverter Defibrillator for Measurement of Intrathoracic Impedance: A Report of Two Cases
by: Xuqing Ying, et al.
Published: (2024-11-01)

Clinical, morphological and genetic characteristics of young patients with hypertrophic cardiomyopathy with indications for implantable cardioverter-defibrillator
by: V. G. Davydova, et al.
Published: (2024-12-01)

Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry
by: Nikias Milaras, et al.
Published: (2025-06-01)

Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators
by: Carmelo La Greca, et al.
Published: (2025-08-01)

Implantable cardioverter defibrillator: decision-making on turning off in patients with end-stage heart failure
by: V. K. Lebedeva, et al.
Published: (2020-09-01)

CARDIAC RESYNCHRONIZATION THERAPY WITH OR WITHOUT AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IN DIFFERENT GROUPS OF HEART FAILURE PATIENTS
by: Perisic Zoran, et al.
Published: (2014-04-01)

Turbulence and deceleration capacity of the heart rate in patients with coronary artery disease and implanted cardioverter defibrillator
by: N. V. Melnik, et al.
Published: (2019-08-01)

Implantable cardioverter-defibrillators in sudden cardiac death prevention: guidelines and clinical practice (literature review)
by: I. V. Talibullin, et al.
Published: (2022-04-01)